NasdaqCM - Nasdaq Real Time Price USD

Bionano Genomics, Inc. (BNGO)

0.7861 +0.0271 (+3.57%)
At close: April 26 at 4:00 PM EDT
0.7760 -0.01 (-1.28%)
After hours: April 26 at 7:54 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
36,116.0000
36,116.0000
27,802.0000
17,981.0000
8,503.0000
Cost of Revenue
26,550.0000
26,550.0000
21,857.0000
14,107.0000
5,730.0000
Gross Profit
9,566.0000
9,566.0000
5,945.0000
3,874.0000
2,773.0000
Operating Expense
147,531.0000
147,531.0000
137,643.0000
80,975.0000
41,324.0000
Operating Income
-137,965.0000
-137,965.0000
-131,698.0000
-77,101.0000
-38,551.0000
Net Non Operating Interest Income Expense
-1,808.0000
-1,808.0000
1,209.0000
-691.0000
-2,519.0000
Other Income Expense
-92,658.0000
-92,658.0000
-223.0000
-360.0000
-7.0000
Pretax Income
-232,431.0000
-232,431.0000
-130,712.0000
-78,152.0000
-41,077.0000
Tax Provision
62.0000
62.0000
1,884.0000
-5,717.0000
29.0000
Net Income Common Stockholders
-232,493.0000
-232,493.0000
-132,596.0000
-72,435.0000
-41,106.0000
Diluted NI Available to Com Stockholders
-232,493.0000
-232,493.0000
-132,596.0000
-72,435.0000
-41,106.0000
Basic EPS
-7.17
-6.81
-4.58
-2.50
-2.16
Diluted EPS
-7.17
-6.81
-4.58
-2.50
-2.16
Basic Average Shares
31,608.2500
34,150.0000
28,921.0000
28,960.2000
18,995.2940
Diluted Average Shares
31,608.2500
34,150.0000
28,921.0000
28,960.2000
18,995.2940
Total Operating Income as Reported
-215,245.0000
-215,245.0000
-131,698.0000
-77,101.0000
-38,551.0000
Total Expenses
174,081.0000
174,081.0000
159,500.0000
95,082.0000
47,054.0000
Net Income from Continuing & Discontinued Operation
-232,493.0000
-232,493.0000
-132,596.0000
-72,435.0000
-41,106.0000
Normalized Income
-171,441.8000
-171,441.8000
-132,596.0000
-72,156.0188
-41,106.0000
Interest Income
3,311.0000
3,311.0000
1,507.0000
236.0000
--
Interest Expense
5,119.0000
5,119.0000
298.0000
927.0000
2,519.0000
Net Interest Income
-1,808.0000
-1,808.0000
1,209.0000
-691.0000
-2,519.0000
EBIT
-227,312.0000
-227,312.0000
-130,414.0000
-77,225.0000
-38,558.0000
EBITDA
-213,400.0000
-213,400.0000
-120,574.0000
-73,855.0000
-37,079.0000
Reconciled Cost of Revenue
26,550.0000
26,550.0000
21,857.0000
14,107.0000
5,730.0000
Reconciled Depreciation
13,912.0000
13,912.0000
9,840.0000
3,370.0000
1,479.0000
Net Income from Continuing Operation Net Minority Interest
-232,493.0000
-232,493.0000
-132,596.0000
-72,435.0000
-41,106.0000
Total Unusual Items Excluding Goodwill
-77,280.0000
-77,280.0000
--
-301.0000
--
Total Unusual Items
-77,280.0000
-77,280.0000
--
-301.0000
--
Normalized EBITDA
-136,120.0000
-136,120.0000
-120,574.0000
-73,554.0000
-37,079.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0001
0.0003
Tax Effect of Unusual Items
-16,228.8000
-16,228.8000
--
-22.0188
--
12/31/2020 - 8/21/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVGR Avinger, Inc.
3.7301
-3.11%
 
POAI Predictive Oncology Inc.
1.5100
-9.04%
 
NSTGQ NanoString Technologies, Inc.
0.2900
+1.75%
 
RMD ResMed Inc.
218.06
+18.89%
 
ISRG Intuitive Surgical, Inc.
375.33
+0.59%
 
ZJYL Jin Medical International Ltd.
4.0400
+3.06%
 
SDCCQ SmileDirectClub, Inc.
0.0026
+18.18%
 
INND InnerScope Hearing Technologies, Inc.
0.0002
-20.00%
 
STAA STAAR Surgical Company
46.96
+0.15%
 
ANGO AngioDynamics, Inc.
5.81
+0.52%